首页> 外国专利> Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals

Composition for oral ingestion, useful for treating renal insufficiency, comprises defined amounts of protein, carbohydrates, fats and minerals

机译:用于治疗肾功能不全的口服摄入组合物,包含确定量的蛋白质,碳水化合物,脂肪和矿物质

摘要

Composition for oral ingestion comprises defined amounts of protein, carbohydrates, fats and minerals. Composition for oral ingestion comprises (per daily portion): (a) protein (4-6 g); (b) carbohydrates (60-80 g), including less than 15% sugar and less than 1 g lactose; (c) fat (18-25 g), including less than 5 g saturated fatty acids (FA), 8-13 g monounsaturated FA, 5-8 g polyunsaturated FA and 1-3 g omega-3 FA, where the ratio of omega-6 FA to omega-3 FA is less than 5; and (d) sodium (less than 300 mg), potassium (less than 80 mg), calcium (more than 200 mg), magnesium (more than 40 mg) and phosphorus (less than 15 mg), where the quotient of phosphorus to protein is less than 2. ACTIVITY : Nephrotropic. No biological data given. MECHANISM OF ACTION : None given in source material.
机译:口服摄入的组合物包含确定量的蛋白质,碳水化合物,脂肪和矿物质。口服摄入的组合物包含(每天):(a)蛋白质(4-6克); (b)碳水化合物(60-80克),包括少于15%的糖和少于1克的乳糖; (c)脂肪(18-25克),包括少于5克的饱和脂肪酸(FA),8-13克的单不饱和脂肪酸,5-8克的多不饱和脂肪酸和1-3克的Omega-3脂肪酸,其比例为omega-6 FA至omega-3 FA小于5; (d)钠(少于300毫克),钾(少于80毫克),钙(超过200毫克),镁(超过40毫克)和磷(少于15毫克),其中磷与蛋白质小于2。活性:肾病。没有给出生物学数据。作用机理:原始材料中没有给出。

著录项

  • 公开/公告号DE20215514U1

    专利类型

  • 公开/公告日2003-01-02

    原文格式PDF

  • 申请/专利权人 BARTZ VOLKER;

    申请/专利号DE2002215514U

  • 发明设计人

    申请日2002-10-09

  • 分类号A23L1/29;

  • 国家 DE

  • 入库时间 2022-08-21 23:41:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号